Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treatment with rituximab, dexamethasone, high-dose cytarabine, and oxaliplatin (R-DHAOx) produces a strong long-term antitumor effect in previously treated patients with follicular non-Hodgkin's lymphoma.
Machover D, Delmas-Marsalet B, Misra SC, Ulusakarya A, Gumus Y, Frénoy N, Guettier C, Saffroy R, Innominato P, Almohamad W, Brahimi N, Haydar M, Goldschmidt E. Machover D, et al. Among authors: haydar m. Biomed Pharmacother. 2010 Feb;64(2):83-7. doi: 10.1016/j.biopha.2009.11.001. Epub 2009 Dec 9. Biomed Pharmacother. 2010. PMID: 20044233 Clinical Trial.
Symptoms in cancer patients and an unusual tumor: Case 1. Regression of hypertrophic pulmonary osteoarthropathy following chemotherapy for lung metastases of a nasopharyngeal carcinoma.
Ulusakarya A, Gumus Y, Brahimi N, Delmas-Marsalet B, Almohamad W, Misra SC, Goldschmidt E, Haydar M, Machover D. Ulusakarya A, et al. Among authors: haydar m. J Clin Oncol. 2005 Dec 20;23(36):9422-3. doi: 10.1200/JCO.2004.00.8474. J Clin Oncol. 2005. PMID: 16361641 No abstract available.
Clinical Relevance of the First Domomedicine Platform Securing Multidrug Chronotherapy Delivery in Metastatic Cancer Patients at Home: The inCASA European Project.
Innominato PF, Komarzynski S, Mohammad-Djafari A, Arbaud A, Ulusakarya A, Bouchahda M, Haydar M, Bossevot-Desmaris R, Plessis V, Mocquery M, Bouchoucha D, Afshar M, Beau J, Karaboué A, Morère JF, Fursse J, Rovira Simon J, Levi F. Innominato PF, et al. Among authors: haydar m. J Med Internet Res. 2016 Nov 25;18(11):e305. doi: 10.2196/jmir.6303. J Med Internet Res. 2016. PMID: 27888171 Free PMC article.
Circadian rest-activity rhythm as an objective biomarker of patient-reported outcomes in patients with advanced cancer.
Innominato PF, Komarzynski S, Palesh OG, Dallmann R, Bjarnason GA, Giacchetti S, Ulusakarya A, Bouchahda M, Haydar M, Ballesta A, Karaboué A, Wreglesworth NI, Spiegel D, Lévi FA. Innominato PF, et al. Among authors: haydar m. Cancer Med. 2018 Sep;7(9):4396-4405. doi: 10.1002/cam4.1711. Epub 2018 Aug 7. Cancer Med. 2018. PMID: 30088335 Free PMC article.
Home-Based e-Health Platform for Multidimensional Telemonitoring of Symptoms, Body Weight, Sleep, and Circadian Activity: Relevance for Chronomodulated Administration of Irinotecan, Fluorouracil-Leucovorin, and Oxaliplatin at Home-Results From a Pilot Study.
Innominato P, Komarzynski S, Karaboué A, Ulusakarya A, Bouchahda M, Haydar M, Bossevot-Desmaris R, Mocquery M, Plessis V, Lévi F. Innominato P, et al. Among authors: haydar m. JCO Clin Cancer Inform. 2018 Dec;2:1-15. doi: 10.1200/CCI.17.00125. JCO Clin Cancer Inform. 2018. PMID: 30652550 Free article.
34 results